Skip to main content
HVIVO PLC logo

HVIVO PLC — Investor Relations & Filings

Ticker · HVO ISIN · GB00B9275X97 LEI · 213800VT5KBM7JLIV118 IL Professional, scientific and technical activities
Open in API
Filings indexed 760 across all filing types
Latest filing 2026-05-29 Director's Dealing
Country GB United Kingdom
Listing IL HVO

About HVIVO PLC

https://hvivo.com/

hVIVO plc is a full-service contract research organization (CRO) and a leading specialist in human challenge trials. The company provides end-to-end clinical development solutions for a global biopharma client base, focusing on infectious and respiratory diseases. Its services span from preclinical consultancy to Phase III clinical trials, including first-in-human studies, biometry, and consulting. hVIVO operates a state-of-the-art quarantine facility in London and provides advanced laboratory services under its hLAB brand. Through subsidiaries such as CRS and Venn Life Sciences, it offers early-phase clinical trial expertise and patient recruitment across multiple clinical sites. The company's integrated approach is designed to accelerate the development of vaccines and therapeutics.

Recent filings

Filing Released Lang Actions
Grant of awards under Long Term Incentive Plan
Director's Dealing Classification · 97% confidence The document is an RNS announcement detailing the grant of share options to senior management (CEO and CFO) under the company’s Long Term Incentive Plan, including transaction details by persons discharging managerial responsibilities (date, volume, price, and insider status). This matches the definition of a Director’s Dealing report (insider share transactions by directors).
2026-05-29 English
Group of companies' accounts made up to 2025-12-31
Annual Report Classification · 94% confidence The document is the full Annual Report & Accounts for hVIVO plc for the year ended 31 December 2025. It includes a strategic report, corporate governance section, independent auditor’s report, full financial statements (income statement, balance sheet, cash flows, notes), and comprehensive business commentary. This matches the definition of an Annual Report category. FY 2025
2026-05-29 English
Capital Markets Day
Regulatory Filings Classification · 82% confidence The document is an RNS release announcing an upcoming Capital Markets Day event (investor meeting) on 11 June 2026. It contains event details and speakers but does not include substantive financial statements or the actual presentation materials. It is not a financial report itself, nor a notice of report publication, but rather a regulatory news service announcement. Therefore, it falls under the fallback category of Regulatory Filings (RNS).
2026-05-20 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is an RNS announcement titled “Result of AGM” stating that all resolutions at the Annual General Meeting were duly passed and noting that voting results will be published shortly. This is clearly an announcement of shareholder vote outcomes at an AGM, matching the Declaration of Voting Results & Voting Rights Announcements category.
2026-05-13 English
Holding(s) in Company
Major Shareholding Notification Classification · 95% confidence The document is a TR-1 standard form for notification of major holdings under the UK/EU transparency rules, showing a shareholder (Octopus Investments Limited) crossing a voting rights threshold. This is a major shareholding notification, fitting the MRQ classification.
2026-05-12 English
£6m Influenza HCT contract signed
Regulatory Filings Classification · 95% confidence The document is a press release announcing a £6 million Clinical Trial Agreement signed by hVIVO plc to conduct a human challenge trial. It provides details about the study, the company's capabilities, and contact information. There is no financial data, no regulatory filing format, no voting results, no management changes, no earnings data, and no report attached or referenced as being published. The document is an announcement of a contract and business update related to clinical trials, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2026-05-07 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.